Investigation of Plasma Biomarkers in HIV-1/HCV Mono- And Coinfected Individuals by Multiplex iTRAQ Quantitative Proteomics

OMICS A Journal of Integrative Biology - United States
doi 10.1089/omi.2011.0004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Identification of TPD52 and DNAJB1 as Two Novel Bile Biomarkers for Cholangiocarcinoma by iTRAQ‑based Quantitative Proteomics Analysis

Oncology Reports
MedicineCancer ResearchOncology
2019English

Recent Advances in Management of the HIV/HCV Coinfected Patient

Future Virology
Virology
2015English

HCV Viremia Is Associated With Drug Use in Young HIV-1 and HCV Coinfected Pregnant and Non-Pregnant Women

Addiction
MedicinePsychiatryMental Health
2005English

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases
Infectious Diseases
2020English

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

HIV Clinical Trials
2009English

iTRAQ Quantitative Proteomics in the Analysis of Tears in Dry Eye Patients

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2012English

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Soluble Adhesion Molecules in Patients Coinfected With HIV and HCV: A Predictor of Outcome

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy